Association for Accessible Medicines

01/29/2026

Bob Hoffman Named Chair of the Association for Accessible Medicines Board of Directors

Biosimilars Council
Lupin

01/26/2026

“An Injection of Support for the Biosimilar Red Tape Elimination Act”

READ: https://biosimilarsrr.com/2026/01/23/an-injection-of-support-for-the-biosimilar-red-tape-elimination-act/
Biosimilars Council

Thirty-seven organizations representing manufacturers, payers, employers, and consumters supported the Biosimilar Red Tape Elimination Act.

01/14/2026

We’re excited to welcome you to in vibrant South Florida — and now is the perfect time to start planning your travel.

Access! 2026 attendees can take advantage of exclusive travel savings, including:
✅ Hotel discounts when you book through the official conference block by February 3
✅ Airline savings with special rates from major carriers

While you’re planning, explore the full Access! 2026 agenda and discover the industry-leading speakers joining us this year.

Book early to save on travel and ensure you don’t miss a moment of the learning, networking, and energy that define Access! — all set against a backdrop of sun, sand, and fun. 🌴

Visit the Access! 2026 website for hotel booking, airline discount details, and the full speaker lineup. https://access.accessiblemeds.org

01/07/2026

Comprising only 1.2 percent of total U.S. healthcare spending in 2024, generic medicines saved Americans $467 billion—providing patients the health and financial outcomes necessary to thrive. https://accessiblemeds.org/resources/blog/2025-savingsreport

01/02/2026

A decade after the first entered to the U.S. market, $56.2 billion have been saved by the healthcare system and 3.3 billion additional days of patient care have been possible. But due to harmful policies that impeded biosimilar uptake, we are currently experiencing a biosimilar void. Policymakers must ACT NOW to safeguard enormous benefits to Americans—$20.2 billion in 2024, alone. MORE: https://accessiblemeds.org/resources/blog/2025-savings-report

12/30/2025

Generic medicines give America's patients the confidence to thrive! Last year, comprised 90% of all prescriptions filled, but only 12% of prescription spending. In sharp contrast, brand drugs supported patients less often— making up only 10% of prescriptions filled but adding up to 88% of the total drug spend. Learn more about what makes generic medicines unique in AAM’s : https://accessiblemeds.org/resources/blog/2025-savings-report

12/29/2025

Join us at , February 23–25 in Miami, Florida! 🌴 AAM’s annual meeting brings together policymakers, influential speakers and industry leaders to discuss the future of and .

Discussions center around hot topics — including breakthroughs that shape the policy impacting our industry. It’s an opportunity to hear first-hand from world-renowned speakers and learn about where our industry is heading and what the future may hold.

Register today: https://access.accessiblemeds.org

12/26/2025

In 2024, & saved America’s patients and the U.S. healthcare system $467 billion—and $3.4 trillion in the past 10 years. Learn more, including what can be done to help safeguard this important industry: https://accessiblemeds.org/resources/blog/2025-savings-report

12/23/2025

From our AAM family to you and yours, please have a safe and happy holiday season! And remember to visit https://accessiblemeds.org to learn how a healthy and medicines industry will help America's patients THRIVE in 2026!

12/22/2025

Reserve your spot now and save before hotel rates increase.

brings together policymakers, industry leaders, and expert voices to discuss the landscape shaping generics and biosimilars. Here’s a snapshot of the sessions you won’t want to miss:
🔹 State of the Industry: A forward look at 2026 and beyond
🔹 Healthcare Innovation & the Political Landscape: Insights from a former commissioner
🔹 Policy Priorities from Washington, D.C.: What’s happening on Capitol Hill
🔹 Reid Strategic Conversation: The power of narrative in healthcare
🔹 Wall Street Perspectives: Market trends influencing medicines
🔹 Biosimilars Panel: Wins, challenges, and what’s needed next
🔹 Global & U.S. Trends: Cost savings, access, and pipeline outlook
🔹 CEOs Unplugged: Leadership perspectives on opportunity and change

Register now: https://access.accessiblemeds.org/

12/19/2025

Over the next decade, 118 biologics are expected to lose patent exclusivity, presenting a $234 billion opportunity for biosimilars in the U.S. But of these 118 biologics, only 12 molecules currently have biosimilars in development. Closing this biosimilar void requires coordinated action across an entire ecosystem of stakeholders – manufacturers, providers, payers, and policymakers. Learn more on what needs to change: https://accessiblemeds.org/resources/blog/2025-savings-report

12/17/2025

Book Your Access! 2026 Hotel Before Rates Go Up

The holiday season is around the corner, and rooms for Access! 2026 are filling fast. The discounted group rate ends December 20, and once it closes, higher rates and limited availability are likely.

brings together policymakers, influential speakers, and industry leaders to chart the future of generics and biosimilars. Staying at the conference hotel ensures you’re steps away from sessions, networking opportunities, and the full Access! experience.

Secure your spot before the year-end rush. 👉 Book now and lock in the best rate! https://access.accessiblemeds.org